Please find below recent articles from Spanish authors that have been published in the European Journal of Neurology

Following the big success of last year’s 1st Autumn School, EAN again welcomed 61 participants from 22 countries - Albania, Armenia, Austria, Denmark, Georgia, Greece, Israel, Italy, Kyrgyzstan, Latvia, Luxembourg, Moldova, Montenegro, Poland, Portugal, Romania, Russia, Serbia, Switzerland, Turkey and Ukraine. Loutraki, formerly known for its’ natural thermal springs, is close to Corinth and the archaeological site and village of ancient Corinth, about 80 kilometres west of Athens.

Below are three reports from those who took part in the EAN clincial Fellowships in 2019. Keep visitng EANpages over the next months to read more reports from other particpants from 2019.

European Working Group of People with Dementia involved in RADAR-AD website section on Patient Engagement

On 16 October, EAN participated in an event in the European Parliament organized by Global Alliance of Mental Illness Advocacy Networks-Europe (GAMIAN Europe). The event brought together the MEP Alliance for Mental Health, organizations and societies focused on brain and mental health as well as several policy makers from the EU institutions. This MEP Alliance is endorsed by 26 members of the European Parliament.

The two European Reference Networks (ERNs) for Rare Neurological Diseases and Rare Neuromuscular Diseases (ERN-RND and ERN-EuroNMD) are launching a new joint educational program in collaboration with the European Academy of Neurology.

Globalisation has created convergence of individual countries’ health problems and, consequently, mutual dependence for generating solutions. This means that in today’s world, we can no longer consider health of particular countries or regions, such as European Union (EU), in isolation.

Open letter on the future of research. Addition research to official title Commissioner Mariya Gabriel

The Scientific Committee is fully committed to a great mission: To increase and share the best clinical knowledge and the cutting-edge information from translational research in all neurological fields. Main actions are i) to facilitate exchanges and synergies with the Scientific Panels ii) to support the Guideline Production Group (update and diffusion of expertise and best clinical practice), iii) to interact positively with other scientific societies with reciprocal exchanges and liaise with the European Affairs sub-Committee to increase the awareness of Neurology in Europe.

In a recent article published in the August 2019 issue of the EAN Pages, we presented the framework based on which the collaboration between the EAN and the EFNR is currently unfolding. The Memorandum of Understanding between the two organizations, signed in 2017, is the guiding document that formally governs this partnership, which focuses on three key pillars for development: facilitating evidence-based clinical guideline production, promoting multidisciplinary education, and hosting joint sessions within the main scientific events organized annualy by these institutions. This article will focus on the latter priority for our collaboration, with the goal of disseminating relevant updates how our community benefits from the interaction between the EAN and the EFNR.

This month’s selected paper addresses the risk of neurological deficits in people with cavernomas treated with antithrombotic medication. Perhaps counter-intuitively, the authors report a lower risk of intracerebral haemorrhage in patients taking antithrombotic medication (mostly antiplatelet therapy). The study therefore provides reassurance for clinicians managing patients with this relatively common, and often incidental, vascular finding that antithrombotic therapy does not appear harmful; conversely, there could be some benefit, but this requires further evaluation in a randomised controlled trial.